Candel Therapeutics
$12.78
61
-$0.19-1.46% 20:00 Today
-$0.01-0.08%20:19After hours
Statistics
Day High
13.05
Day Low
12.76
52W High
14
52W Low
4.35
Volume
535,343
Avg. Volume
1,540,490
Mkt Cap
977.91M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
5NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.52
-0.3
-0.09
0.13
Expected EPS
-0.332452
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-38.18MNet Income
Analyst Ratings
21.60Average Price Target
The highest estimate is 26.00.
From 6 ratings within the last 6 months. This is not an investment recommendation.
From 6 ratings within the last 6 months. This is not an investment recommendation.
Buy 83%
Hold 17%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow CADL. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Marker Therapeutics
MRKR
Mkt Cap22.84M
Nkarta
NKTX
Mkt Cap197.68M
Precigen
PGEN
Mkt Cap2.49B
Iovance Biotherapeutics
IOVA
Mkt Cap3.63B
CRISPR Therapeutics
CRSP
Mkt Cap5.58B
BioNTech
BNTX
Mkt Cap25.64B
About
Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
Show more...
CEO
Paul-Peter Tak
Employees
55
Country
United States
ISIN
US1374041093
Listings
0 Comments
Share your thoughts
FAQ
What is Candel Therapeutics stock price today?▼
The current price of CADL is $12.78 USD — it has decreased by -1.46% in the past 24 hours. Watch Candel Therapeutics stock price performance more closely on the chart.
What is Candel Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Candel Therapeutics stocks are traded under the ticker CADL.
Is Candel Therapeutics stock price growing?▼
CADL stock has fallen by -2.22% compared to the previous week, the month change is a +21.6% rise, over the last year Candel Therapeutics has showed a +161.08% increase.
What is Candel Therapeutics market cap?▼
Today Candel Therapeutics has the market capitalization of 977.91M
When is the next Candel Therapeutics earnings date?▼
Candel Therapeutics is going to release the next earnings report on November 05, 2026.
What were Candel Therapeutics earnings last quarter?▼
CADL earnings for the last quarter are -0.52 USD per share, whereas the estimation was -0.24 USD resulting in a -118.55% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Candel Therapeutics revenue for the last year?▼
Candel Therapeutics revenue for the last year amounts to 0 USD.
What is Candel Therapeutics net income for the last year?▼
CADL net income for the last year is -38.18M USD.
How many employees does Candel Therapeutics have?▼
As of September 04, 2026, the company has 55 employees.
In which sector is Candel Therapeutics located?▼
Candel Therapeutics operates in the Health & Wellness sector.
When did Candel Therapeutics complete a stock split?▼
Candel Therapeutics has not had any recent stock splits.
Where is Candel Therapeutics headquartered?▼
Candel Therapeutics is headquartered in NEEDHAM, United States.